1-6 of 6
Rose Chang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ravulizumab demonstrates real-world effectiveness in patients with paroxysmal nocturnal hemoglobinuria: A US chart review study

Free
David Dingli, Andrew Messali, Arpita Nag, Yogesh Patel, Maral DerSarkissian, Rose Chang, Zoey Kang, Elizabeth Griffiths
Journal: Blood
Blood (2025) 146 (Supplement 1): 8010.
https://doi.org/10.1182/blood-2025-8010
Published: 2025
Journal Articles

Real-world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy: A retrospective analysis of electronic health records data

Free
Evan Chen, Xiaoqin Yang, Mavis Obeng-Kusi, Uzor Ogbu, Rose Chang, Priyanka Bobbili, Louise Clear, Zhuo Chen, Yidan Ma, Yichuan Grace Hsieh, Christopher Herrick, Mei Sheng Duh, Shawn Murphy, Gabriela Hobbs
Journal: Blood
Blood (2025) 146 (Supplement 1): 2837.
https://doi.org/10.1182/blood-2025-2837
Published: 2025
Journal Articles

Real-World Drug Adherence, Persistence, and Healthcare Resource Utilization in Patients with Paroxysmal Nocturnal Hemoglobinuria in the USA: The Advantage Study

Free
Elizabeth A. Griffiths, Andrew Messali, Mohammed Mahdi, Maral DerSarkissian, Rose Chang, Brendan Rabideau, David Dingli
Journal: Blood
Blood (2024) 144 (Supplement 1): 5074.
https://doi.org/10.1182/blood-2024-203329
Published: 2024
Journal Articles

Real-World Treatment Patterns and Clinical Outcomes with Brentuximab Vedotin or Other Standard Therapies in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Chart Review Study in the United States

Free
Stefan K. Barta, Nicholas Liu, Maral DerSarkissian, Rose Chang, Mingchen Ye, Mei Sheng Duh, Andy Surinach, Michelle A. Fanale, Kristina S. Yu
Journal: Blood
Blood (2022) 140 (Supplement 1): 5167–5169.
https://doi.org/10.1182/blood-2022-162375
Published: 2022
Journal Articles

Time and Personnel Costs Associated with Adverse Event (AE) Management Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Acalabrutinib, Ibrutinib, or Venetoclax

Free
Hetalkumari Patel, Svea K. Wahlstrom, Maral DerSarkissian, Colin Kunzweiler, Felicia Castriota, Rose Chang, Hoi Ching Cheung, Yuqian Gu, Helen Guo, Mei Sheng Duh, Kellie J. Ryan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2999.
https://doi.org/10.1182/blood-2021-147449
Published: 2021
Journal Articles

Real-World Clinical Burden of Sickle Cell Disease in the US Community-Practice Setting: A Single-Center Experience from the Foundation for Sickle Cell Disease Research

Free
Lanetta Bronté-Hall, MPH, MSPH, MD, Matthew Parkin, Courtney Green, Elsa Tchouambou, DO, Lynn Huynh, MPH, MBA, DrPH, Charu Puri-Sharma, MS, Rose Chang, MSPH, MS, ScD, Anjulika Chawla, MD, James Signorovitch, PhD, Gershwin Theophilus Blyden, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5856.
https://doi.org/10.1182/blood-2019-128700
Published: 2019